JANE STREET GROUP, LLC

Position in CELU — Celularity Inc

CIK 1595888 NEW YORK, NY

Back to CELU Full portfolio

Position in CELU

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$17,169

-$28,687 QoQ

Shares Held

28,713

-30.5% QoQ

Ownership

0.099%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#13

of 39 holders

Holding Since

Sep 2021

6 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in CELU Over Time

Shares Held

Position Value (USD)

Derivatives in CELU

reported options exposure · as of Dec 31, 2021

CallValue

$67,072

CallShares

1,310

PutValue

PutShares

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JANE STREET GROUP, LLC holds $1,363,916,985 across 292 Biotechnology names. CELU ranks #274 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BBIO	BridgeBio Pharma, Inc.	2,934,193	$218,538,693
2	MDGL	Madrigal Pharmaceuticals, Inc.	191,541	$102,847,939
3	AXSM	Axsome Therapeutics, Inc.	403,995	$98,885,855
4	TGTX	Tg Therapeutics, Inc.	1,752,646	$96,290,370
5	EXEL	Exelixis, Inc.	1,402,438	$76,306,651
6	QURE	uniQure N.V.	1,610,483	$74,178,846
7	HALO	Halozyme Therapeutics, Inc.	694,684	$54,372,915
8	TVTX	Travere Therapeutics, Inc.	938,699	$53,327,489

All Filings in CELU

Export CSV

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$17,169	28,713	-30.5%	Shares	Defined	2026-08-14
2025-12-31	$45,856	41,312	+26.7%	Shares	Defined	2026-02-12
2022-12-31	$42,077	32,618	+94.0%	Shares	Defined	2023-02-15
2022-03-31	$146,441	16,813	-45.1%	Shares	Defined	2022-05-17
2021-12-31	$67,072	13,100	-26.4%	Call	Defined	2022-02-15
2021-09-30	$126,024	17,800	—	Call	Defined	2021-11-16
2021-09-30	$216,902	30,636	—	Shares	Defined	2021-11-16
No filing history on record for this holder in this stock.